speb/financial-data huggingface dataset:
Financial ratios for SANDHAR.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 120111777.3530817
Buffett classification: The Gruesome
Stock price: 6.580267558528428
Shares outstanding: 60190708
Book value: 127559245.10272336
P/B ratio: 3.104996136174229
Market cap (USD): 396070963.17725754
Debt to equity: 0.684276344990196
Current ratio: 0.932277653079979
Quick ratio: 0.5440253953284193
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SANDHAR.NS — annual report dated 2025-03-31
Total revenue: 454115291.0918868
Gross profit: 175372924.94739303
Operating income: 24860030.395136777
Net income: 16558615.852232872
Capital expenditures: 35722398.877718024
Operating cash flow: 28871814.355856907
Depreciation & amortization: 19944026.186579376
Net tangible assets: 126284054.2436287
Owner earnings: 780243.161094226
Return on net tangible assets (%): 0.6178477288898023
Capex to operating income (%): 143.69410781052864
Buffett classification: The Gruesome
Stock price: 4.409149258956704
P/E ratio: 16.027294668986023
Shares outstanding: 60190708
Book value: 133189291.5595043
P/B ratio: 1.9925762234099165
Market cap (USD): 265389815.57427937
Debt to equity: 0.7975279057021972
Current ratio: 0.9445762853079209
Quick ratio: 0.6094389019083788
Effective tax rate (%): 23.267978954850005
Interest coverage ratio: 3.7565241507960767
COGS to revenue (%): 61.381409437739535
R&D to revenue (%): 0.03506755640400976
SG&A to revenue (%): 1.8333649032300714
Free cash flow (dilution-adjusted): -8090741.173719897
Buyback yield (%): 0
Retained earnings: 87889174.6551321
Inventory turnover: 5.8228259176029225
Receivables turnover: 7.098870979532164
Capitalized R&D asset: 289097.4682331767
ROCI (R&D-adjusted, %): 13.551719846550988
Rosenberg metric: 292.4763483110377
FCF margin (%): -1.7816491389810514
Revenue growth (%): 9.080266830425616
Rule of 40 score: 7.298617691444565
Financial ratios for SANDHAR.NS — quarterly report dated 2025-03-31
Total revenue: 118550946.92541501
Gross profit: 44761421.55716623
Operating income: 7000806.640168342
Net income: 4981482.347439794
Capital expenditures: 0
Depreciation & amortization: 5134989.4786065
Net tangible assets: 126284054.2436287
Owner earnings: 10116471.826046294
Return on net tangible assets (%): 8.010886161866072
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.409149258956704
P/E ratio: 13.318817425433368
Shares outstanding: 60190708
Book value: 133189291.5595043
P/B ratio: 1.9925762234099165
Market cap (USD): 265389815.57427937
Debt to equity: 0.7975279057021972
Current ratio: 0.9445762853079209
Quick ratio: 0.6094389019083788
Effective tax rate (%): 23.295177372116925
Interest coverage ratio: 4.089660588677184
COGS to revenue (%): 62.24288146316756
Buyback yield (%): 0
Retained earnings: 87889174.6551321
Inventory turnover: 1.541436153767631
Receivables turnover: 1.8532251461988305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8188067090714233
Rule of 40 score: 0
Financial ratios for SANDHAR.NS — quarterly report dated 2025-06-30
Total revenue: 127555394.33653171
Gross profit: 47276257.89843202
Operating income: 3767282.939386848
Net income: 3277860.9875965365
Capital expenditures: 0
Depreciation & amortization: 5874455.885794524
Owner earnings: 9152316.87339106
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.245377954598643
P/E ratio: 28.67065765123552
Shares outstanding: 60190708
Market cap (USD): 375913720.8148842
Effective tax rate (%): 22.859629121711304
Interest coverage ratio: 1.8717595418737827
COGS to revenue (%): 62.936684767950936
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.595424283520696
Rule of 40 score: 7.595424283520696
Financial ratios for SANDHAR.NS — quarterly report dated 2025-09-30
Total revenue: 143221386.69673055
Gross profit: 52531882.750845544
Operating income: 8387418.263810597
Net income: 8272367.531003382
Capital expenditures: 0
Depreciation & amortization: 4926110.484780158
Net tangible assets: 120089177.00112739
Owner earnings: 13198478.01578354
Return on net tangible assets (%): 10.990564133568535
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.0152198421645995
P/E ratio: 18.26003584998886
Shares outstanding: 60190708
Book value: 138623573.8444194
P/B ratio: 2.1776211989335317
Market cap (USD): 301869633.0755355
Debt to equity: 0.7762883124316693
Current ratio: 0.9675889234803938
Quick ratio: 0.6313560022990898
Effective tax rate (%): 23.313064889676678
Interest coverage ratio: 4.278852015873929
COGS to revenue (%): 63.321202257257056
Buyback yield (%): 0
Inventory turnover: 1.5767762541092105
Receivables turnover: 1.5502130427795173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.411476941446195
Revenue growth (%): 12.28171685069388
Rule of 40 score: 12.28171685069388
Financial ratios for SANDHAR.NS — quarterly report dated 2025-12-31
Total revenue: 131963640.41439234
Gross profit: 50214492.59218002
Operating income: 6541639.7460176
Net income: 3725854.9626824106
Capital expenditures: 0
Depreciation & amortization: 5505558.649883035
Owner earnings: 9231413.612565445
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.127882366046564
P/E ratio: 18.207596177725218
Shares outstanding: 60190708
Market cap (USD): 368841578.1530579
Effective tax rate (%): 25.241394725078226
Interest coverage ratio: 3.5556436866515697
COGS to revenue (%): 61.94823632138638
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -7.86038073083062
Rule of 40 score: -7.86038073083062
Financial ratios for SBXD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.1
Shares outstanding: 20455000
Market cap (USD): 206595500
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBXD — annual report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 194751233
Buffett classification: The Gruesome
Stock price: 10.1
Shares outstanding: 20455000
Book value: 194751233
P/B ratio: 1.0608174172637972
Market cap (USD): 206595500
Debt to equity: 0
Current ratio: 7.476000159546887
Quick ratio: 7.476000159546887
Buyback yield (%): 0
Retained earnings: -9903951
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBXD — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -184633
Net income: 1930794
Capital expenditures: 0
Operating cash flow: -198031
Net tangible assets: 196682027
Owner earnings: 1930794
Return on net tangible assets (%): 0.9816829882478281
Buffett classification: The Gruesome
Stock price: 10.18
P/E ratio: 26.96195192236976
Shares outstanding: 20455000
Book value: 196682027
P/B ratio: 1.0587235812858486
Market cap (USD): 208231900
Debt to equity: 0
Current ratio: 6.6811562830429025
Quick ratio: 6.6811562830429025
Free cash flow (dilution-adjusted): -198031
Buyback yield (%): 0
Retained earnings: -10088584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.08898354394582586
Rule of 40 score: 0
Financial ratios for SBXD — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -720310
Net income: 1462590
Capital expenditures: 0
Operating cash flow: -256965
Net tangible assets: 198144617
Owner earnings: 1462590
Return on net tangible assets (%): 0.7381426869648444
Buffett classification: The Gruesome
Stock price: 10.96
P/E ratio: 66.06585049024808
Shares outstanding: 20455000
Book value: 198144617
P/B ratio: 1.1314301816233545
Market cap (USD): 224186800.00000003
Debt to equity: 0
Current ratio: 10.197775305895439
Quick ratio: 10.197775305895439
Free cash flow (dilution-adjusted): -256965
Buyback yield (%): 0
Retained earnings: -10808894
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3439542755262697
Rule of 40 score: 0
Financial ratios for SBXD — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -53000
Operating income: -1617598
Net income: 637702
Capital expenditures: 0
Operating cash flow: -398697
Net tangible assets: 198835319
Owner earnings: 637702
Return on net tangible assets (%): 0.3207186747340396
Buffett classification: The Gruesome
Stock price: 10.47
P/E ratio: 53.12807764458511
Shares outstanding: 20455000
Book value: 198835319
P/B ratio: 1.0770915905538896
Market cap (USD): 214163850
Debt to equity: 0
Current ratio: 1.1598974074302515
Quick ratio: 1.1598974074302515
Free cash flow (dilution-adjusted): -398697
Buyback yield (%): 0
Retained earnings: -12373492
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7657653823571736
Rule of 40 score: 0
Financial ratios for SBXD — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: 0
Operating income: -454059
Net income: 1684846
Capital expenditures: 0
Operating cash flow: -134738
Net tangible assets: 200520165
Owner earnings: 1684846
Return on net tangible assets (%): 0.840237688812993
Buffett classification: The Gruesome
Stock price: 10.58
P/E ratio: 37.86152459476425
Shares outstanding: 20455000
Book value: 200520165
P/B ratio: 1.0792625270381162
Market cap (USD): 216413900
Debt to equity: 0
Current ratio: 0.4984029916094256
Quick ratio: 0.4984029916094256
Free cash flow (dilution-adjusted): -134738
Buyback yield (%): 0
Retained earnings: -12827551
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.21296587066897424
Rule of 40 score: 0
Financial ratios for SBXD — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -53000
Operating income: -2976600
Net income: 5715932
Capital expenditures: 0
Operating cash flow: -988431
Net tangible assets: 200520165
Owner earnings: 5715932
Return on net tangible assets (%): 2.850552212541816
Buffett classification: The Gruesome
Stock price: 10.58
P/E ratio: 37.86152459476425
Shares outstanding: 20455000
Book value: 200520165
P/B ratio: 1.0792625270381162
Market cap (USD): 216413900
Debt to equity: 0
Current ratio: 0.4984029916094256
Quick ratio: 0.4984029916094256
Free cash flow (dilution-adjusted): -988431
Buyback yield (%): 0
Retained earnings: -12827551
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3961053753659076
Rule of 40 score: 0
Financial ratios for SCSP.L — annual report dated 2023-06-30
Total revenue: 0
Operating income: -221241.77215189874
Net income: -221241.77215189874
Capital expenditures: 0
Operating cash flow: -156834.17721518988
Net tangible assets: 914426.582278481
Owner earnings: -221241.77215189874
Return on net tangible assets (%): -24.194591062808954
Buffett classification: The Gruesome
Shares outstanding: 185406000
Book value: 914426.582278481
Debt to equity: 0
Current ratio: 8.184955690600042
Quick ratio: 8.184955690600042
Free cash flow (dilution-adjusted): -185248.1012658228
Retained earnings: -383406.32911392406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.194591062808954
Rule of 40 score: 0
Financial ratios for SCSP.L — annual report dated 2024-06-30
Total revenue: 0
Operating income: -332167.0886075949
Net income: -332167.0886075949
Capital expenditures: 0
Operating cash flow: -372481.0126582278
Net tangible assets: 582259.493670886
Owner earnings: -332167.0886075949
Return on net tangible assets (%): -57.04794721567007
Buffett classification: The Gruesome
Shares outstanding: 185406000
Book value: 582259.493670886
Debt to equity: 0
Current ratio: 7.665193514265429
Quick ratio: 7.665193514265429
Free cash flow (dilution-adjusted): -372481.0126582278
Retained earnings: -715573.4177215189
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -57.04794721567007
Rule of 40 score: 0
Financial ratios for SCSP.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 377375
Buffett classification: The Gruesome
Shares outstanding: 185406000
Book value: 377375
Debt to equity: 0
Current ratio: 5.893030794165316
Quick ratio: 5.893030794165316
Retained earnings: -904250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCSP.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 172587.67123287672
Buffett classification: The Gruesome
Shares outstanding: 185406000
Book value: 172587.67123287672
Debt to equity: 0
Current ratio: 1.57820438096899
Quick ratio: 1.57820438096899
Retained earnings: -1350273.9726027397
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCSP.L — annual report dated 2025-06-30
Total revenue: 0
Operating income: -728516.4383561644
Net income: -575886.301369863
Capital expenditures: 0
Operating cash flow: -420197.2602739726
Net tangible assets: 172587.67123287672
Owner earnings: -575886.301369863
Return on net tangible assets (%): -333.67754327758774
Buffett classification: The Gruesome
Shares outstanding: 185406000
Book value: 172587.67123287672
Debt to equity: 0
Current ratio: 1.57820438096899
Quick ratio: 1.57820438096899
Free cash flow (dilution-adjusted): -538554.794520548
Retained earnings: -1350273.9726027397
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -422.11383533483075
Rule of 40 score: 0
Financial ratios for SGP.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.6165413533834583
Shares outstanding: 2431644122
Market cap (USD): 6362497401.924811
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SGP.AX — annual report dated 2022-06-30
Total revenue: 1937931034.4827588
Gross profit: 738620689.6551725
Operating income: 442068965.5172414
Net income: 952413793.1034483
Capital expenditures: 15172413.793103449
Depreciation & amortization: 17931034.482758623
Net tangible assets: 7100689655.172414
Owner earnings: 955172413.7931035
Return on net tangible assets (%): 13.451825951825953
Capex to operating income (%): 3.43213728549142
Buffett classification: The Great
Stock price: 1.986206896551724
P/E ratio: 5.071060877161477
Shares outstanding: 2431644122
Book value: 7145517241.37931
P/B ratio: 0.6759130461692887
Market cap (USD): 4829748325.075862
Debt to equity: 0.4316185696361356
Current ratio: 1.1549435308103824
Quick ratio: 0.9417475728155339
Effective tax rate (%): 4.169468728984533
Interest coverage ratio: 8.78082191780822
COGS to revenue (%): 61.88612099644127
SG&A to revenue (%): 13.558718861209965
Free cash flow (dilution-adjusted): 617931034.4827586
Buyback yield (%): 0.24274842376699474
Retained earnings: 1159310344.8275862
Inventory turnover: 1.6161710037174721
Receivables turnover: 23.416666666666668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.1712761111472645
FCF margin (%): 31.88612099644128
Rule of 40 score: 31.88612099644128
Financial ratios for SGP.AX — annual report dated 2023-06-30
Total revenue: 1859602649.0066226
Gross profit: 788741721.8543047
Operating income: 508609271.5231788
Net income: 291390728.4768212
Capital expenditures: 15231788.079470199
Depreciation & amortization: 11258278.145695364
Net tangible assets: 6698013245.033113
Owner earnings: 287417218.54304636
Return on net tangible assets (%): 4.2910816689737
Capex to operating income (%): 2.9947916666666665
Buffett classification: The Great
Stock price: 2.2781456953642385
P/E ratio: 19.011035862909093
Shares outstanding: 2431644122
Book value: 6739072847.682119
P/B ratio: 0.8220180601100628
Market cap (USD): 5539639589.192053
Debt to equity: 0.3839426100628931
Current ratio: 1.2094792276184905
Quick ratio: 0.45523698069046237
Effective tax rate (%): 14.951456310679612
Interest coverage ratio: 9.365853658536587
COGS to revenue (%): 57.58547008547008
SG&A to revenue (%): 14.458689458689458
Free cash flow (dilution-adjusted): 204635761.589404
Buyback yield (%): 0.17932168103170606
Retained earnings: 990066225.1655629
Inventory turnover: 1.2544608223429015
Receivables turnover: 8.50909090909091
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.143660839863371
FCF margin (%): 11.004273504273506
Revenue growth (%): -4.0418561900497325
Rule of 40 score: 6.9624173142237735
Financial ratios for SGP.AX — annual report dated 2024-06-30
Total revenue: 1992666666.6666667
Gross profit: 789333333.3333334
Operating income: 468000000
Net income: 203333333.33333334
Capital expenditures: 2666666.6666666665
Depreciation & amortization: 10666666.666666666
Net tangible assets: 6558000000
Owner earnings: 211333333.33333334
Return on net tangible assets (%): 3.222527193249975
Capex to operating income (%): 0.5698005698005697
Buffett classification: The Great
Stock price: 2.513333333333333
P/E ratio: 30.056715868655733
Shares outstanding: 2431644122
Book value: 6595333333.333334
P/B ratio: 0.9266449347963206
Market cap (USD): 6111532226.626666
Debt to equity: 0.47811583948246233
Current ratio: 1.6984126984126984
Quick ratio: 0.8483853311439519
Effective tax rate (%): 9.763313609467456
Interest coverage ratio: 6.324324324324325
COGS to revenue (%): 60.38808966209434
SG&A to revenue (%): 15.59049849447976
Free cash flow (dilution-adjusted): 73333333.33333333
Buyback yield (%): 0.25089180200227384
Retained earnings: 808666666.6666666
Inventory turnover: 1.1622665808113328
Receivables turnover: 5.883858267716535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.60841593907963
FCF margin (%): 3.6801605888256943
Revenue growth (%): 7.15550807217474
Rule of 40 score: 10.835668661000435
Financial ratios for SLB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.07
Shares outstanding: 1484000000
Market cap (USD): 40171880000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLB — annual report dated 2022-12-31
Total revenue: 28091000000
Gross profit: 5161000000
Operating income: 4151000000
Net income: 3492000000
Capital expenditures: 1715000000
Operating cash flow: 3720000000
Depreciation & amortization: 1669000000
Net tangible assets: 1711000000
Owner earnings: 3446000000
Return on net tangible assets (%): 201.40268848626533
Capex to operating income (%): 41.31534569983137
Buffett classification: The Good
Stock price: 49.04
P/E ratio: 20.840595647193588
Shares outstanding: 1484000000
Book value: 17989000000
P/B ratio: 4.045547834787926
Market cap (USD): 72775360000
Debt to equity: 0.679637556284396
Current ratio: 1.2483774338492262
Quick ratio: 0.9156265601597604
Effective tax rate (%): 18.23928822289862
Interest coverage ratio: 8.471428571428572
COGS to revenue (%): 81.62756754832509
R&D to revenue (%): 2.2569506247552598
SG&A to revenue (%): 1.338506995122993
Free cash flow (dilution-adjusted): 1692000000
Buyback yield (%): 0
Retained earnings: 10719000000
Inventory turnover: 5.733933483370842
Receivables turnover: 4.151788353532368
Capitalized R&D asset: 634000000
ROCI (R&D-adjusted, %): 14.404795649480857
FCF margin (%): 6.023281478053469
Rule of 40 score: 6.023281478053469
Financial ratios for SLB — annual report dated 2023-12-31
Total revenue: 33135000000
Gross profit: 6563000000
Operating income: 5488000000
Net income: 4275000000
Capital expenditures: 2092000000
Operating cash flow: 6637000000
Depreciation & amortization: 1759000000
Net tangible assets: 2866000000
Owner earnings: 3942000000
Return on net tangible assets (%): 137.54361479413816
Capex to operating income (%): 38.11953352769679
Buffett classification: The Good
Stock price: 48.66
P/E ratio: 16.8915649122807
Shares outstanding: 1484000000
Book value: 21359000000
P/B ratio: 3.3808436724565754
Market cap (USD): 72211440000
Debt to equity: 0.560185401938293
Current ratio: 1.3227323628219485
Quick ratio: 0.9952220977976857
Effective tax rate (%): 19.06474820143885
Interest coverage ratio: 10.910536779324056
COGS to revenue (%): 80.1931492379659
R&D to revenue (%): 2.145767315527388
SG&A to revenue (%): 1.0985362909310397
Free cash flow (dilution-adjusted): 4252000000
Buyback yield (%): 0.9610665567671826
Retained earnings: 13497000000
Inventory turnover: 6.056986551173923
Receivables turnover: 4.241551459293395
Capitalized R&D asset: 1135780000
ROCI (R&D-adjusted, %): 16.109311746183284
Rosenberg metric: 2.2113564668769716
FCF margin (%): 12.832352497359286
Revenue growth (%): 17.95592894521377
Rule of 40 score: 30.78828144257306
Financial ratios for SLB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.96
Shares outstanding: 1484000000
Market cap (USD): 59300640000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.75
Shares outstanding: 1484000000
Market cap (USD): 54537000000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLB — annual report dated 2024-12-31
Total revenue: 36289000000
Gross profit: 7460000000
Operating income: 6326000000
Net income: 4579000000
Capital expenditures: 2129000000
Operating cash flow: 6602000000
Depreciation & amortization: 1885000000
Net tangible assets: 3525000000
Owner earnings: 4335000000
Return on net tangible assets (%): 122.97872340425533
Capex to operating income (%): 33.654758141005374
Buffett classification: The Good
Stock price: 36.75
P/E ratio: 11.91024241100677
Shares outstanding: 1484000000
Book value: 22350000000
P/B ratio: 2.4401342281879197
Market cap (USD): 54537000000
Debt to equity: 0.5402237136465324
Current ratio: 1.4495355553820934
Quick ratio: 1.1080321598626182
Effective tax rate (%): 19.270098730606488
Interest coverage ratio: 12.35546875
COGS to revenue (%): 79.442806360054
R&D to revenue (%): 2.0639863319463196
SG&A to revenue (%): 1.0609275538041831
Free cash flow (dilution-adjusted): 4157000000
Buyback yield (%): 3.1849936740194726
Retained earnings: 16395000000
Inventory turnover: 6.589485714285714
Receivables turnover: 4.529896392460367
Capitalized R&D asset: 1434590000
ROCI (R&D-adjusted, %): 16.97880564738985
Rosenberg metric: 1.261603375527426
FCF margin (%): 11.45526192510127
Revenue growth (%): 9.518635883506866
Rule of 40 score: 20.973897808608136
Financial ratios for SLB — quarterly report dated 2025-03-31
Total revenue: 8490000000
Gross profit: 1606000000
Operating income: 1338000000
Net income: 829000000
Capital expenditures: 449000000
Operating cash flow: 660000000
Depreciation & amortization: 640000000
Net tangible assets: 1915000000
Owner earnings: 1020000000
Return on net tangible assets (%): 53.26370757180157
Capex to operating income (%): 33.5575485799701
Buffett classification: The Good
Stock price: 40.35
P/E ratio: 18.057720144752714
Shares outstanding: 1484000000
Book value: 20748000000
P/B ratio: 2.8860323886639674
Market cap (USD): 59879400000
Debt to equity: 0.6748602274918064
Current ratio: 1.2366985900505454
Quick ratio: 0.9274408087257249
Effective tax rate (%): 22.013170272812793
Interest coverage ratio: 9.10204081632653
COGS to revenue (%): 81.08362779740872
R&D to revenue (%): 2.025912838633687
SG&A to revenue (%): 1.1307420494699647
Free cash flow (dilution-adjusted): 120000000
Buyback yield (%): 3.8410538515749995
Retained earnings: 16804000000
Inventory turnover: 1.4804301075268818
Receivables turnover: 0.9867503486750349
Capitalized R&D asset: 172000000
ROCI (R&D-adjusted, %): 4.255277598765794
FCF margin (%): 1.4134275618374559
Rule of 40 score: 1.4134275618374559
Financial ratios for SLB — quarterly report dated 2025-06-30
Total revenue: 8546000000
Gross profit: 1612000000
Operating income: 1345000000
Net income: 1048000000
Capital expenditures: 320000000
Operating cash flow: 1142000000
Depreciation & amortization: 633000000
Net tangible assets: 2751000000
Owner earnings: 1361000000
Return on net tangible assets (%): 49.472918938567794
Capex to operating income (%): 23.79182156133829
Buffett classification: The Great
Stock price: 32.9
P/E ratio: 26.01150772509323
Shares outstanding: 1484000000
Book value: 21551000000
P/B ratio: 2.2654911605029926
Market cap (USD): 48823600000
Debt to equity: 0.6356085564474966
Current ratio: 1.3147844674029212
Quick ratio: 0.9770573566084788
Effective tax rate (%): 18.443579766536967
Interest coverage ratio: 9.471830985915492
COGS to revenue (%): 81.13737421015679
R&D to revenue (%): 2.1062485373274047
SG&A to revenue (%): 1.0180201263749122
Free cash flow (dilution-adjusted): 745000000
Buyback yield (%): 0
Retained earnings: 17433000000
Inventory turnover: 1.4628691983122364
Receivables turnover: 0.9953412532028885
Capitalized R&D asset: 295240000
ROCI (R&D-adjusted, %): 4.018547552463789
Rosenberg metric: 0.03488372093023256
FCF margin (%): 8.717528668382869
Revenue growth (%): 0.6595995288574794
Rule of 40 score: 9.377128197240348
Financial ratios for SLB — quarterly report dated 2025-09-30
Total revenue: 8928000000
Gross profit: 1558000000
Operating income: 1316000000
Net income: 774000000
Capital expenditures: 577000000
Operating cash flow: 1682000000
Depreciation & amortization: 638000000
Net tangible assets: 3539000000
Owner earnings: 835000000
Return on net tangible assets (%): 23.5942356597909
Capex to operating income (%): 43.84498480243161
Buffett classification: The Good
Stock price: 33.72
P/E ratio: 18.87607695209355
Shares outstanding: 1484000000
Book value: 26922000000
P/B ratio: 1.8587207488299533
Market cap (USD): 50040480000
Debt to equity: 0.4741846816729812
Current ratio: 1.3869060340528603
Quick ratio: 1.007836432286101
Effective tax rate (%): 22.6
Interest coverage ratio: 9.267605633802816
COGS to revenue (%): 82.54928315412187
R&D to revenue (%): 1.9041218637992832
SG&A to revenue (%): 0.8064516129032258
Free cash flow (dilution-adjusted): 1016000000
Buyback yield (%): 0.22781556052220123
Retained earnings: 17746000000
Inventory turnover: 1.3850779928584853
Receivables turnover: 0.9809910998791341
Capitalized R&D asset: 347360000
ROCI (R&D-adjusted, %): 3.168824945608279
Rosenberg metric: -0.3
FCF margin (%): 11.379928315412187
Revenue growth (%): 4.46992745143927
Rule of 40 score: 15.849855766851457
Financial ratios for SLB — annual report dated 2025-12-31
Total revenue: 35708000000
Gross profit: 6507000000
Operating income: 5458000000
Net income: 3451000000
Capital expenditures: 1946000000
Operating cash flow: 6489000000
Depreciation & amortization: 2109000000
Net tangible assets: 4327000000
Owner earnings: 3614000000
Return on net tangible assets (%): 83.52207071874278
Capex to operating income (%): 35.65408574569439
Buffett classification: The Good
Stock price: 37.96
P/E ratio: 16.323569979716027
Shares outstanding: 1484000000
Book value: 27291000000
P/B ratio: 2.0641471547396577
Market cap (USD): 56332640000
Debt to equity: 0.42636766699644574
Current ratio: 1.3255213640377692
Quick ratio: 0.9836967597309966
Effective tax rate (%): 19.575856443719413
Interest coverage ratio: 9.78136200716846
COGS to revenue (%): 81.77719278593032
R&D to revenue (%): 1.9855494567043799
SG&A to revenue (%): 0.9521675814943431
Free cash flow (dilution-adjusted): 4211000000
Buyback yield (%): 4.285259842251313
Retained earnings: 18067000000
Inventory turnover: 5.803060413354531
Receivables turnover: 4.1095638163194845
Capitalized R&D asset: 1445460000
ROCI (R&D-adjusted, %): 13.088910826625789
Rosenberg metric: -1.2723631508678237
FCF margin (%): 11.792875546096113
Revenue growth (%): -1.6010361266499489
Rule of 40 score: 10.191839419446165
Financial ratios for SLB — quarterly report dated 2025-12-31
Total revenue: 9745000000
Gross profit: 1729000000
Operating income: 1458000000
Net income: 824000000
Capital expenditures: 600000000
Operating cash flow: 3005000000
Depreciation & amortization: 198000000
Net tangible assets: 4327000000
Owner earnings: 422000000
Return on net tangible assets (%): 9.75271550727987
Capex to operating income (%): 41.1522633744856
Buffett classification: The Good
Stock price: 37.96
P/E ratio: 16.21083165467626
Shares outstanding: 1484000000
Book value: 27291000000
P/B ratio: 2.0641471547396577
Market cap (USD): 56332640000
Debt to equity: 0.42636766699644574
Current ratio: 1.3255213640377692
Quick ratio: 0.9836967597309966
Effective tax rate (%): 15.1643690349947
Interest coverage ratio: 11.571428571428571
COGS to revenue (%): 82.25756798358132
R&D to revenue (%): 1.9189327860441252
SG&A to revenue (%): 0.8619805028219599
Free cash flow (dilution-adjusted): 2330000000
Buyback yield (%): 0
Retained earnings: 18067000000
Inventory turnover: 1.5930047694753577
Receivables turnover: 1.1215329727241339
Capitalized R&D asset: 360300000
ROCI (R&D-adjusted, %): 3.619100754678786
Rosenberg metric: 1.0058823529411764
FCF margin (%): 23.909697280656747
Revenue growth (%): 9.150985663082437
Rule of 40 score: 33.06068294373918
Financial ratios for SUDARSCHEM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.707239878675986
Shares outstanding: 79607576
Market cap (USD): 533947108.3919293
Buyback yield (%): 0
Retained earnings: 77107609.12567586
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUDARSCHEM.NS — annual report dated 2023-03-31
Total revenue: 278461023.14250916
Gross profit: 105043848.96467723
Operating income: 14246528.62362972
Net income: 5452984.165651645
Capital expenditures: 23215712.545676008
Operating cash flow: 34963093.78806334
Depreciation & amortization: 13913154.689403167
Net tangible assets: 95872107.18635811
Owner earnings: -3849573.690621197
Return on net tangible assets (%): -4.01532187368983
Capex to operating income (%): 162.9569782155193
Buffett classification: The Gruesome
Stock price: 4.703045066991474
P/E ratio: 68.65928934110657
Shares outstanding: 79607576
Book value: 100879902.55785626
P/B ratio: 3.711324139981455
Market cap (USD): 374398017.60194886
Debt to equity: 1.0009997295417667
Current ratio: 1.172730814650603
Quick ratio: 0.6753176542363463
Effective tax rate (%): 25.059006679053887
Interest coverage ratio: 2.933340021066359
COGS to revenue (%): 62.277001003864555
SG&A to revenue (%): 2.670410928345067
Free cash flow (dilution-adjusted): 11396102.314250913
Buyback yield (%): 0
Retained earnings: 72471863.5809988
Inventory turnover: 2.881634313540952
Receivables turnover: 4.702630485492013
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.362408199684277
FCF margin (%): 4.092530504141214
Rule of 40 score: 4.092530504141214
Financial ratios for SUDARSCHEM.NS — annual report dated 2024-03-31
Total revenue: 302457608.8259983
Gross profit: 125309269.69660631
Operating income: 22853339.72898429
Net income: 42864492.145341165
Capital expenditures: 32009833.313346922
Operating cash flow: 23198824.799136586
Depreciation & amortization: 16928528.600551624
Net tangible assets: 133528120.87780309
Owner earnings: 27783187.43254587
Return on net tangible assets (%): 20.806993500621022
Capex to operating income (%): 140.06632594162897
Buffett classification: The Gruesome
Stock price: 7.287188099808062
P/E ratio: 13.533704738989124
Shares outstanding: 79607576
Book value: 137790742.2952392
P/B ratio: 4.210118697515786
Market cap (USD): 580115380.4817659
Debt to equity: 0.406483864314204
Current ratio: 1.383522667983777
Quick ratio: 0.8761568196416438
Effective tax rate (%): 24.033111597560197
Interest coverage ratio: 5.44294976151715
COGS to revenue (%): 58.56964214489449
SG&A to revenue (%): 2.6960257616979506
Free cash flow (dilution-adjusted): 13637246.67226286
Buyback yield (%): 0
Retained earnings: 110293080.70512052
Inventory turnover: 3.3757769652650818
Receivables turnover: 4.3090929903181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.768452126512022
FCF margin (%): 4.508812565567914
Revenue growth (%): 8.617574342247645
Rule of 40 score: 13.126386907815558
Financial ratios for SUDARSCHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 140971571.90635452
Buffett classification: The Gruesome
Stock price: 13.31032011466794
Shares outstanding: 79607576
Book value: 144750119.44577163
P/B ratio: 7.32021724175309
Market cap (USD): 1059602320.1127567
Debt to equity: 0.4616148229810999
Current ratio: 1.205713387035285
Quick ratio: 0.7051234230918392
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUDARSCHEM.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.291875509966195
Shares outstanding: 79607576
Market cap (USD): 1058133989.8421726
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUDARSCHEM.NS — quarterly report dated 2025-03-31
Total revenue: 157750759.87841943
Gross profit: 76806172.5508534
Operating income: 9106850.596212298
Net income: 46761.74888940846
Capital expenditures: 0
Depreciation & amortization: 6675239.653963057
Net tangible assets: 386026654.1968669
Owner earnings: 6722001.402852465
Return on net tangible assets (%): 1.7413308976909043
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.520364103162562
P/E ratio: 4903.090039784154
Shares outstanding: 79607576
Book value: 472094809.44587314
P/B ratio: 1.9426357641310485
Market cap (USD): 917108260.8901855
Debt to equity: 0.5887431812255607
Current ratio: 2.1159693730155626
Quick ratio: 1.270151796810078
Effective tax rate (%): 96.22641509433961
Interest coverage ratio: 3.7095238095238092
COGS to revenue (%): 51.31169408626056
Buyback yield (%): 0
Inventory turnover: 0.28087187107153594
Receivables turnover: 1.1015941849150006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1428727360593367
Rule of 40 score: 0
Financial ratios for SUDARSCHEM.NS — annual report dated 2025-03-31
Total revenue: 391115267.71101236
Gross profit: 183761982.6981529
Operating income: 27145195.23030161
Net income: 7049333.645078326
Capital expenditures: 10907177.928454524
Operating cash flow: 8335281.739537058
Depreciation & amortization: 19429506.663549215
Net tangible assets: 386026654.1968669
Owner earnings: 15571662.380173014
Return on net tangible assets (%): 4.033830879520494
Capex to operating income (%): 40.18087855297158
Buffett classification: The Good
Stock price: 11.520364103162562
P/E ratio: 130.09857485331088
Shares outstanding: 79607576
Book value: 472094809.44587314
P/B ratio: 1.9426357641310485
Market cap (USD): 917108260.8901855
Debt to equity: 0.5887431812255607
Current ratio: 2.1159693730155626
Quick ratio: 1.270151796810078
Effective tax rate (%): 39.274924471299094
Interest coverage ratio: 4.807453416149069
COGS to revenue (%): 53.01590148254424
SG&A to revenue (%): 3.3090925394548063
Free cash flow (dilution-adjusted): -2723871.872808043
Buyback yield (%): 0
Retained earnings: 114024433.0137947
Inventory turnover: 0.7195009210277055
Receivables turnover: 2.731209059620295
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4066116728238507
FCF margin (%): -0.6964371114299378
Revenue growth (%): 29.312424716026296
Rule of 40 score: 28.61598760459636
Financial ratios for SUDARSCHEM.NS — quarterly report dated 2025-06-30
Total revenue: 293341914.34589285
Gross profit: 150257430.37678447
Operating income: 87935876.43341915
Net income: 6435759.419611515
Capital expenditures: 0
Depreciation & amortization: 11584366.955300726
Owner earnings: 18020126.37491224
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.38848584132928
P/E ratio: 176.69552483751085
Shares outstanding: 79607576
Market cap (USD): 1145432480.1385446
Effective tax rate (%): 33.09002433090025
Interest coverage ratio: 17.040816326530614
COGS to revenue (%): 48.77737444652758
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 85.95277421926544
Rule of 40 score: 85.95277421926544
Financial ratios for SUDARSCHEM.NS — quarterly report dated 2025-09-30
Total revenue: 269154453.2130778
Gross profit: 134904171.36414883
Operating income: 77080045.09582864
Net income: 2175873.7316798195
Capital expenditures: 0
Depreciation & amortization: 10958286.358511837
Net tangible assets: 380958286.3585118
Owner earnings: 13134160.090191657
Return on net tangible assets (%): 3.447663579059513
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.041713641488162
P/E ratio: 138.29749921200863
Shares outstanding: 79607576
Book value: 441916572.7170236
P/B ratio: 2.709638958599929
Market cap (USD): 1197434361.8850057
Debt to equity: 0.6449308638195826
Current ratio: 2.187789996711848
Quick ratio: 1.1617039932775564
Effective tax rate (%): 34.576271186440685
Interest coverage ratio: 15.681192660550458
COGS to revenue (%): 49.87852894362067
Buyback yield (%): 0
Inventory turnover: 0.42399857575218086
Receivables turnover: 1.9779618889809445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.742924729956966
Revenue growth (%): -8.24548417731212
Rule of 40 score: -8.24548417731212
Financial ratios for SUDARSCHEM.NS — quarterly report dated 2025-12-31
Total revenue: 234265344.7699677
Gross profit: 113790798.70780885
Operating income: -5235602.094240838
Net income: -12843934.499275928
Capital expenditures: 0
Depreciation & amortization: 11206416.397460176
Owner earnings: -1637518.1018157527
Buffett classification: The Gruesome
Stock price: 10.556978946195835
Shares outstanding: 79607576
Market cap (USD): 840415503.7896849
Interest coverage ratio: -1.291208791208791
COGS to revenue (%): 51.4265335235378
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.962486047180462
Rule of 40 score: -12.962486047180462
Financial ratios for SUVEN.NS — annual report dated 2022-03-31
Capital expenditures: 2607358.565211658
Buffett classification: The Gruesome
Stock price: 1.1262033495977846
Shares outstanding: 282562686
Market cap (USD): 318223043.444547
Buyback yield (%): 0
Retained earnings: -28571040.48529606
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUVEN.NS — annual report dated 2023-03-31
Total revenue: 1649110.8404384898
Gross profit: 1604311.814859927
Operating income: -16068099.878197322
Net income: -14405334.957369063
Capital expenditures: 352594.39707673574
Operating cash flow: -14126808.769792937
Depreciation & amortization: 796967.1132764921
Net tangible assets: 45690779.53714982
Owner earnings: -13960962.241169306
Return on net tangible assets (%): -30.555316373663665
Buffett classification: The Gruesome
Stock price: 0.5907429963459196
Shares outstanding: 282562686
Book value: 45714908.64799026
P/B ratio: 3.651367414261027
Market cap (USD): 166921927.78319123
Debt to equity: 0.004276890563077742
Current ratio: 22.605169997124786
Quick ratio: 22.605169997124786
Interest coverage ratio: -456.1517980636238
COGS to revenue (%): 2.7165563696525643
R&D to revenue (%): 851.9779602930748
SG&A to revenue (%): 20.537402505317893
Free cash flow (dilution-adjusted): -14479403.166869672
Buyback yield (%): 0
Retained earnings: -40771266.747868456
Receivables turnover: 16.768887787961358
Capitalized R&D asset: 14050060.90133983
ROCI (R&D-adjusted, %): -11.156938372146472
FCF margin (%): -878.0127333963602
Rule of 40 score: -878.0127333963602
Financial ratios for SUVEN.NS — annual report dated 2024-03-31
Total revenue: 1402206.4995802855
Gross profit: 1316117.0404125196
Operating income: -16104616.860534836
Net income: -12600575.60858616
Capital expenditures: 290346.56433625135
Operating cash flow: -9907494.903465644
Depreciation & amortization: 779721.7891833553
Net tangible assets: 32359035.85561818
Owner earnings: -12111200.383739056
Return on net tangible assets (%): -37.427568725402274
Buffett classification: The Gruesome
Stock price: 1.199616122840691
Shares outstanding: 282562686
Book value: 32382851.660870604
P/B ratio: 10.46747696554339
Market cap (USD): 338966753.8387716
Debt to equity: 0.002628123326640513
Current ratio: 18.990204274901785
Quick ratio: 18.93779270647598
Interest coverage ratio: -847.8308080808081
COGS to revenue (%): 6.139570683314803
R&D to revenue (%): 978.5957410416488
SG&A to revenue (%): 23.182245788078333
Free cash flow (dilution-adjusted): -9907494.903465644
Buyback yield (%): 0
Retained earnings: -52748339.12939201
Inventory turnover: 1.0134105025409372
Receivables turnover: 9.09253499222395
Capitalized R&D asset: 23135473.889399543
ROCI (R&D-adjusted, %): -20.905298738500232
Rosenberg metric: -0.020511994678964328
FCF margin (%): -706.5646113059095
Revenue growth (%): -14.971967608469164
Rule of 40 score: -721.5365789143787
Financial ratios for SUVEN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 22992331.58146202
Buffett classification: The Gruesome
Stock price: 1.6804825609173435
Shares outstanding: 282562686
Book value: 23014309.60344004
P/B ratio: 20.632453215889072
Market cap (USD): 474841666.1889632
Debt to equity: 0.0012674139668811548
Current ratio: 10.402428892445117
Quick ratio: 10.36315176117006
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUVEN.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.491082876792167
Shares outstanding: 282562686
Market cap (USD): 421324382.71500176
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SUVEN.NS — quarterly report dated 2025-03-31
Total revenue: 171498.71405190552
Gross profit: 171498.71405190552
Operating income: -5280266.541968669
Net income: -5137350.946925415
Capital expenditures: 0
Depreciation & amortization: 157435.11807341594
Net tangible assets: 12836789.805938741
Owner earnings: -4979915.828851999
Return on net tangible assets (%): -38.794090299337284
Buffett classification: The Gruesome
Stock price: 1.3265258489905474
Shares outstanding: 282562686
Book value: 12857937.806873977
P/B ratio: 29.15138590410769
Market cap (USD): 374826706.93919945
Debt to equity: 0
Current ratio: 3.21350166056374
Quick ratio: 3.2033892531721024
COGS to revenue (%): 0
R&D to revenue (%): 2544.3081117927745
Buyback yield (%): 0
Retained earnings: -70221335.04793079
Inventory turnover: 0
Receivables turnover: 1.0976430976430975
Capitalized R&D asset: 4363455.693242927
ROCI (R&D-adjusted, %): -13.611430414553164
Rule of 40 score: 0
Financial ratios for SUVEN.NS — annual report dated 2025-03-31
Total revenue: 778092.1206453121
Gross profit: 778092.1206453121
Operating income: -20060240.82300678
Net income: -18791793.313069906
Capital expenditures: 4357703.99812953
Operating cash flow: -18015501.51975684
Depreciation & amortization: 680582.1837736731
Net tangible assets: 12836789.805938741
Owner earnings: -22468915.12742576
Return on net tangible assets (%): -175.03531231017638
Buffett classification: The Gruesome
Stock price: 1.3265258489905474
Shares outstanding: 282562686
Book value: 12857937.806873977
P/B ratio: 29.15138590410769
Market cap (USD): 374826706.93919945
Debt to equity: 0
Current ratio: 3.21350166056374
Quick ratio: 3.2033892531721024
Interest coverage ratio: -3682.302575107296
COGS to revenue (%): 0
R&D to revenue (%): 2162.952612758797
SG&A to revenue (%): 39.687190119895426
Free cash flow (dilution-adjusted): -22522200.140285246
Buyback yield (%): 0
Retained earnings: -70221335.04793079
Inventory turnover: 0
Receivables turnover: 4.980022446689113
Capitalized R&D asset: 30659979.117896497
ROCI (R&D-adjusted, %): -41.39662951612886
Rosenberg metric: -0.039209119911513546
FCF margin (%): -2894.5416028125846
Revenue growth (%): -44.50944843871327
Rule of 40 score: -2939.051051251298
Financial ratios for SUVEN.NS — quarterly report dated 2025-06-30
Total revenue: 218429.6747016148
Gross profit: 218429.6747016148
Operating income: -6098373.508073953
Net income: -6028188.626257899
Capital expenditures: 0
Depreciation & amortization: 160121.69435993448
Owner earnings: -5868066.931897964
Buffett classification: The Gruesome
Stock price: 2.880294874795226
Shares outstanding: 282562686
Market cap (USD): 813863856.2941728
COGS to revenue (%): 0
R&D to revenue (%): 2222.553168693416
Buyback yield (%): 0
Capitalized R&D asset: 7778230.970920222
ROCI (R&D-adjusted, %): -55.49310185045794
Rosenberg metric: 0.010755457130545563
Revenue growth (%): 27.365196823286514
Rule of 40 score: 27.365196823286514
Financial ratios for SUVEN.NS — quarterly report dated 2025-09-30
Total revenue: 103630.21420518601
Gross profit: 103630.21420518601
Operating income: -9141815.107102593
Net income: -8715885.005636979
Capital expenditures: 0
Depreciation & amortization: 148455.4678692221
Net tangible assets: 31689379.932356257
Owner earnings: -8567429.537767757
Return on net tangible assets (%): -27.035649028335936
Buffett classification: The Gruesome
Stock price: 2.3022547914317926
Shares outstanding: 282562686
Book value: 31710721.53325817
P/B ratio: 20.5145536357809
Market cap (USD): 650531297.723337
Debt to equity: 0
Current ratio: 5.110951871736359
Quick ratio: 5.106534816464372
COGS to revenue (%): 0
R&D to revenue (%): 7650.271975630984
Buyback yield (%): 0
Inventory turnover: 0
Receivables turnover: 0.8609159876369766
Capitalized R&D asset: 12620593.10421567
ROCI (R&D-adjusted, %): -15.562810707094629
Rosenberg metric: -0.023646999869902922
Revenue growth (%): -52.55671449094553
Rule of 40 score: -52.55671449094553
Financial ratios for SUVEN.NS — quarterly report dated 2025-12-31
Total revenue: 312877.35323604767
Gross profit: 312877.35323604767
Operating income: -11662726.968920575
Net income: -11353659.351676507
Capital expenditures: 0
Depreciation & amortization: 149916.45315807062
Owner earnings: -11203742.898518436
Buffett classification: The Gruesome
Stock price: 1.852177787679626
Shares outstanding: 282562686
Market cap (USD): 523356330.6362928
COGS to revenue (%): 0
R&D to revenue (%): 3348.4245380425114
Buyback yield (%): 0
Capitalized R&D asset: 17390273.70423065
ROCI (R&D-adjusted, %): -51.40414716003612
Rosenberg metric: 0.02639345579794092
Revenue growth (%): 201.91711523104257
Rule of 40 score: 201.91711523104257
Financial ratios for TOWN.L — annual report dated 2021-06-30
Total revenue: 29762500
Gross profit: 14283333.333333334
Operating income: 7620833.333333334
Net income: -800000
Capital expenditures: 275000
Operating cash flow: -3161111.111111111
Depreciation & amortization: 3094444.4444444445
Net tangible assets: 209102777.7777778
Owner earnings: 2019444.4444444445
Capex to operating income (%): 3.6085292509568068
Buffett classification: The Great
Stock price: 0.01638888888888889
Shares outstanding: 42004816
Book value: 215826388.8888889
P/B ratio: 0.0031896575102159015
Market cap (USD): 688412.2622222223
Debt to equity: 0.8612246211268059
Current ratio: 0.41178277593760015
Quick ratio: 0.41178277593760015
Interest coverage ratio: 0.691667717130972
COGS to revenue (%): 52.00895982080359
SG&A to revenue (%): 9.230482057025528
Free cash flow (dilution-adjusted): -3436111.111111111
Buyback yield (%): 0
Retained earnings: 195619444.44444445
Receivables turnover: 9.406935908691835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8971389056962575
FCF margin (%): -11.545102431284707
Rule of 40 score: -11.545102431284707
Financial ratios for TOWN.L — annual report dated 2022-06-30
Total revenue: 34318292.68292683
Gross profit: 17652439.024390247
Operating income: 9747560.975609757
Net income: 13429268.292682927
Capital expenditures: 345121.9512195122
Operating cash flow: 5913414.634146342
Depreciation & amortization: 3076829.268292683
Net tangible assets: 212673170.73170733
Owner earnings: 16160975.609756099
Return on net tangible assets (%): 7.598972429927979
Capex to operating income (%): 3.5405980232703618
Buffett classification: The Great
Stock price: 0.013780487804878049
P/E ratio: 0.0431033800217944
Shares outstanding: 42004816
Book value: 218663414.63414633
P/B ratio: 0.0026472048632490072
Market cap (USD): 578846.8546341463
Debt to equity: 1.0369874626332933
Current ratio: 0.945932809991605
Quick ratio: 0.945932809991605
Effective tax rate (%): 0
Interest coverage ratio: 1.060220188353893
COGS to revenue (%): 48.56259550122597
SG&A to revenue (%): 7.537045591841086
Free cash flow (dilution-adjusted): 5568292.68292683
Buyback yield (%): 186.451439451125
Retained earnings: 200051219.51219514
Receivables turnover: 16.54379776601999
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.602133664961862
FCF margin (%): 16.225436196297217
Revenue growth (%): 15.30715727148873
Rule of 40 score: 31.532593467785947